[Federal Register Volume 72, Number 104 (Thursday, May 31, 2007)]
[Notices]
[Pages 30384-30385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-10422]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Applied Research in Antimicrobial Resistance: Studies 
of Susceptibility Testing on Gram-negative Multidrug Resistant 
Organisms, Funding Opportunity Announcement (FOA) CI07-003

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.

    Time and Date: 12 p.m.-4 p.m., June 28, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to FOA CI07-003, ``Applied Research in Antimicrobial 
Resistance: Studies of Susceptibility Testing on Gram-negative 
Multidrug Resistant Organisms.''
    Contact Person for More Information: Trudy Messmer, PhD, 
Scientific Review Administrator, 1600 Clifton Road, Mailstop C-19, 
Atlanta, GA 30333, telephone (404) 639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and

[[Page 30385]]

other committee management activities, for both CDC and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 24, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-10422 Filed 5-30-07; 8:45 am]
BILLING CODE 4163-18-P